Abo T, Miller C A, Balch C M
Eur J Immunol. 1984 Jul;14(7):616-23. doi: 10.1002/eji.1830140707.
Three subpopulations of human granular lymphocytes from blood and lymphoid tissues were characterized using combinations of the monoclonal antibodies (mAb) HNK-1 (Leu-7), Leu-11 and VEP13. Each subpopulation was confirmed to possess natural killer (NK) cell functional capability, but a different level of cytotoxic efficiency (HNK-1+leu-11- less than HNK-1+Leu-11+ less than HNK-1-Leu-11+). In adult from 23 healthy donors, the subpopulations with HNK-1+Leu-11-, HNK-1+Leu-11+ and HNK-1-Leu-11+ phenotypes comprised 4.7 +/- 3.0, 8.0 +/- 6.4 and 3.9 +/- 3.5% of mononuclear cells, respectively. Despite their distinct surface marker phenotypes and NK functional ability, all 3 subpopulations exhibited granular lymphocyte morphology. One of these subpopulations, HNK-1+Leu-11-, also expressed the pan-T cell antigen Leu-4. Different patterns were observed in fetal bone marrow and cord blood, where the vast majority of HNK-1+ cells lacked the Leu-11 antigen (HNK-1+Leu-11+ cells). The HNK-1 antigen was not expressed on granulocytes and their precursors, whereas both Leu-11 and VEP13 antigens were expressed on these myeloid cells from fetal bone marrow and cord blood as well as adult bone marrow and spleen. Cell lines of granular lymphocytes cultured in the presence of interleukin 2 all possessed the HNK-1+Leu-4+ phenotype and NK functional capability but lacked the Leu-11 and VEP13 antigens on their surface after 15 days of culture. Although granular lymphocytes expressing the Fc receptors reacting with the mAb Leu-11 and VEP13, are the most functionally active NK cells, the HNK-1+ subpopulation lacking the Leu-11 and VEP13 antigens appears to be an important population (possibly an immature form of granular lymphocytes) for delineating the cell lineage(s) and differentiation of human granular lymphocytes. Although none of the currently available mAb react both inclusively and exclusively with human granular lymphocytes, the combination usage of these antibodies permits a more precise and comprehensive analysis of these subsets.
利用单克隆抗体(mAb)HNK-1(Leu-7)、Leu-11和VEP13的组合对来自血液和淋巴组织的人类颗粒淋巴细胞的三个亚群进行了表征。每个亚群均被证实具有自然杀伤(NK)细胞功能,但细胞毒性效率水平不同(HNK-1+Leu-11-低于HNK-1+Leu-11+低于HNK-1-Leu-11+)。在23名健康供体的成年人中,具有HNK-1+Leu-11-、HNK-1+Leu-11+和HNK-1-Leu-11+表型的亚群分别占单核细胞的4.7±3.0%、8.0±6.4%和3.9±3.5%。尽管这三个亚群具有不同的表面标志物表型和NK功能能力,但它们均呈现颗粒淋巴细胞形态。其中一个亚群HNK-1+Leu-11-还表达了泛T细胞抗原Leu-4。在胎儿骨髓和脐带血中观察到不同的模式,其中绝大多数HNK-1+细胞缺乏Leu-11抗原(HNK-1+Leu-11+细胞)。HNK-1抗原在粒细胞及其前体上不表达,而Leu-11和VEP13抗原在来自胎儿骨髓和脐带血以及成人骨髓和脾脏的这些髓系细胞上均有表达。在白细胞介素2存在下培养的颗粒淋巴细胞系在培养15天后均具有HNK-1+Leu-4+表型和NK功能能力,但表面缺乏Leu-11和VEP13抗原。虽然表达与mAb Leu-11和VEP13反应的Fc受体的颗粒淋巴细胞是功能最活跃的NK细胞,但缺乏Leu-11和VEP13抗原的HNK-1+亚群似乎是用于描绘人类颗粒淋巴细胞的细胞谱系和分化的一个重要群体(可能是颗粒淋巴细胞的未成熟形式)。尽管目前可用的单克隆抗体均不能既全面又专门地与人类颗粒淋巴细胞反应,但这些抗体的联合使用允许对这些亚群进行更精确和全面的分析。